{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:31:30Z","timestamp":1715988690595},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,10,1]]},"DOI":"10.1038\/sj.bmt.1703678","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T11:01:10Z","timestamp":1034074870000},"page":"453-457","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tyrosine kinase inhibitor STI571 in the treatment of Philadelphia chromosome-positive leukaemia failing myeloablative stem cell transplantation"],"prefix":"10.1038","volume":"30","author":[{"given":"WY","family":"Au","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKW","family":"Lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SK","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TS","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EC","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YL","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,10,7]]},"reference":[{"key":"BF1703678_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia New Engl J Med 2001 344: 1031 1037","journal-title":"New Engl J Med"},{"key":"BF1703678_CR2","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome New Engl J Med 2001 344: 1038 1042","journal-title":"New Engl J Med"},{"key":"BF1703678_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0959-8049(00)00454-8","volume":"37","author":"TI Mughal","year":"2001","unstructured":"Mughal TI, Goldman JM . Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma Eur J Cancer 2001 37: 561 568","journal-title":"Eur J Cancer"},{"key":"BF1703678_CR4","first-page":"993","volume":"86","author":"F Baron","year":"2001","unstructured":"Baron F, Frere P, Fillet G, Beguin Y . Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 Haematologica 2001 86: 993 994","journal-title":"Haematologica"},{"key":"BF1703678_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.bmt.1703222","volume":"28","author":"B Wassmann","year":"2001","unstructured":"Wassmann B, Klein SA, Scheuring U et al. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation Bone Marrow Transplant 2001 28: 721 724","journal-title":"Bone Marrow Transplant"},{"key":"BF1703678_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0165-4608(94)00108-1","volume":"89","author":"YL Kwong","year":"1996","unstructured":"Kwong YL, Chiu EK, Liang RH et al. Essential thrombocythemia with BCR\/ABL rearrangement Cancer Genet Cytogenet 1996 89: 74 76","journal-title":"Cancer Genet Cytogenet"},{"key":"BF1703678_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.bmt.1701294","volume":"22","author":"WY Au","year":"1998","unstructured":"Au WY, Chan AC, Lie AK et al. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia Bone Marrow Transplant 1998 22: 99 102","journal-title":"Bone Marrow Transplant"},{"key":"BF1703678_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1365-2141.2001.02518.x","volume":"112","author":"WY Au","year":"2001","unstructured":"Au WY, Lie AK, Ma SK et al. Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia Br J Haematol 2001 112: 424 426","journal-title":"Br J Haematol"},{"key":"BF1703678_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2796.2001.00823.x","volume":"250","author":"ME O'Dwyer","year":"2001","unstructured":"O'Dwyer ME, Druker BJ . Chronic myelogenous leukaemia \u2013 new therapeutic principles J Intern Med 2001 250: 3 9","journal-title":"J Intern Med"},{"key":"BF1703678_CR10","first-page":"365","volume":"9","author":"AM Carella","year":"1995","unstructured":"Carella AM, Frassoni F, Negrin RS . Autografting in chronic myelogenous leukemia: new questions Leukemia 1995 9: 365 369","journal-title":"Leukemia"},{"key":"BF1703678_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins RH Jr, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433 444","journal-title":"J Clin Oncol"},{"key":"BF1703678_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.bmt.1702101","volume":"25","author":"IW Blau","year":"2000","unstructured":"Blau IW, Basara N, Bischoff M et al. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant Bone Marrow Transplant 2000 25: 41 45","journal-title":"Bone Marrow Transplant"},{"key":"BF1703678_CR13","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1182\/blood.V99.10.3861","volume":"99","author":"E Olavarria","year":"2002","unstructured":"Olavarria E, Craddock C, Dazzi F et al. Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation Blood 2002 99: 3861 3862","journal-title":"Blood"},{"key":"BF1703678_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0301-472X(99)00096-X","volume":"27","author":"F Dazzi","year":"1999","unstructured":"Dazzi F, Szydlo RM, Goldman JM . Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand Exp Hematol 1999 27: 1477 1486","journal-title":"Exp Hematol"},{"key":"BF1703678_CR15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood.V95.1.67","volume":"95","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Craddock C et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia Blood 2000 95: 67 71","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703678","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:30:10Z","timestamp":1648078210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,10,1]]}},"alternative-id":["BF1703678"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703678","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,1]]},"assertion":[{"value":"18 February 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}